S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.19%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
NASDAQ:PRPH

ProPhase Labs (PRPH) News Today

$4.39
+0.03 (+0.69%)
(As of 10/4/2023 ET)
Compare
Today's Range
$4.33
▼
$4.48
50-Day Range
$4.23
▼
$7.48
52-Week Range
$4.05
▼
$12.69
Volume
28,634 shs
Average Volume
55,038 shs
Market Capitalization
$73.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoProPhase Labs (NASDAQ:PRPH) Downgraded to Sell at StockNews.com
americanbankingnews.com - October 4 at 4:29 AM
MarketBeat logoProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average of $7.10
americanbankingnews.com - September 29 at 3:00 AM
finance.yahoo.com logoAre ProPhase Labs, Inc. (NASDAQ:PRPH) Investors Paying Above The Intrinsic Value?
finance.yahoo.com - August 31 at 9:06 AM
insidermonkey.com logoProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2023 Earnings Call Transcript
insidermonkey.com - August 14 at 1:01 PM
finance.yahoo.com logoProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.
finance.yahoo.com - August 10 at 1:17 PM
finance.yahoo.com logoProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023
finance.yahoo.com - August 10 at 8:16 AM
finance.yahoo.com logoProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compound
finance.yahoo.com - August 3 at 10:48 AM
finance.yahoo.com logoProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time
finance.yahoo.com - August 2 at 8:44 AM
finance.yahoo.com logoNavidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea
finance.yahoo.com - June 29 at 12:47 PM
marketbeat.com logoChapin Davis Inc. Invests $229,000 in ProPhase Labs, Inc. (NASDAQ:PRPH)
marketbeat.com - June 23 at 7:18 AM
msn.com logoProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy
msn.com - June 11 at 1:52 AM
marketbeat.com logoHRT Financial LP Invests $204,000 in ProPhase Labs, Inc. (NASDAQ:PRPH)
marketbeat.com - June 9 at 4:36 AM
finance.yahoo.com logoProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023
finance.yahoo.com - June 7 at 9:21 AM
msn.com logoHC Wainwright & Co. Reiterates ProPhase Labs (PRPH) Buy Recommendation
msn.com - June 2 at 3:24 PM
markets.businessinsider.com logoH.C. Wainwright Remains a Buy on Prophase Labs (PRPH)
markets.businessinsider.com - June 2 at 10:24 AM
finance.yahoo.com logoProPhase Labs’ Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testing
finance.yahoo.com - June 1 at 3:25 PM
marketbeat.com logoO Shaughnessy Asset Management LLC Boosts Position in ProPhase Labs, Inc. (NASDAQ:PRPH)
marketbeat.com - May 30 at 6:24 AM
marketbeat.com logoStockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH)
marketbeat.com - May 18 at 4:35 AM
markets.businessinsider.com logoHere's what Wall Street expects from ProPhase Labs's earnings report
markets.businessinsider.com - May 13 at 12:04 AM
msn.com logoHC Wainwright & Co. Maintains ProPhase Labs (PRPH) Buy Recommendation
msn.com - May 12 at 2:01 PM
markets.businessinsider.com logoAnalyst Expectations for ProPhase Labs's Future
markets.businessinsider.com - May 12 at 2:01 PM
msn.com logoRecap: ProPhase Labs Q1 Earnings
msn.com - May 11 at 10:59 PM
finance.yahoo.com logoProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023
finance.yahoo.com - May 11 at 12:59 PM
finance.yahoo.com logoProPhase Labs, Inc. (PRPH) Beats Q1 Earnings and Revenue Estimates
finance.yahoo.com - May 11 at 12:59 PM
msn.com logoProPhase Labs Q1 2023 Earnings Preview
msn.com - May 10 at 9:24 PM
marketwatch.com logoProPhase Labs hires Dr. Matthew Halpert to Drive Company's Key Therapeutic and Diagnostic Oncology Programs
marketwatch.com - May 8 at 11:06 PM
finance.yahoo.com logoProPhase Labs hires Dr. Matthew Halpert to Drive Company’s Key Therapeutic and Diagnostic Oncology Programs
finance.yahoo.com - May 8 at 1:05 PM
marketbeat.com logoProPhase Labs (PRPH) Scheduled to Post Earnings on Thursday
marketbeat.com - May 5 at 9:46 AM
finance.yahoo.com logoProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Time
finance.yahoo.com - May 4 at 10:38 AM
marketbeat.com logoProPhase Labs, Inc. to Post Q1 2023 Earnings of ($0.11) Per Share, Diamond Equity Forecasts (NASDAQ:PRPH)
marketbeat.com - May 4 at 7:04 AM
finance.yahoo.com logoProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?
finance.yahoo.com - May 3 at 9:46 AM
finance.yahoo.com logoProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancers
finance.yahoo.com - May 3 at 9:46 AM
finance.yahoo.com logoDiamond Equity Research Initiates Coverage on ProPhase Labs Inc. (NASDAQ: PRPH)
finance.yahoo.com - May 1 at 8:59 AM
marketbeat.com logoBank of Montreal Can Acquires New Position in ProPhase Labs, Inc. (NASDAQ:PRPH)
marketbeat.com - May 1 at 4:48 AM
marketwatch.com logoProPhase Labs CEO Ted Karkus Named One of Inc Magazine's 10 Most Innovative Healthcare Leaders to Watch in 2023
marketwatch.com - April 29 at 12:58 AM
marketbeat.com logoProPhase Labs, Inc. (NASDAQ:PRPH) Sees Significant Growth in Short Interest
marketbeat.com - April 28 at 4:56 PM
finance.yahoo.com logoProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023
finance.yahoo.com - April 28 at 9:56 AM
markets.businessinsider.com logo7 Small-Cap Biotech Stocks with Massive Potential
markets.businessinsider.com - April 27 at 8:01 PM
finance.yahoo.com logoCOMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee
finance.yahoo.com - April 27 at 9:45 AM
finance.yahoo.com logoCould The Market Be Wrong About ProPhase Labs, Inc. (NASDAQ:PRPH) Given Its Attractive Financial Prospects?
finance.yahoo.com - April 27 at 9:45 AM
finance.yahoo.com logoProPhase Labs Announces Launch of Redesigned Corporate Website
finance.yahoo.com - April 25 at 2:49 PM
marketbeat.com logoNavellier & Associates Inc. Raises Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH)
marketbeat.com - April 21 at 9:29 AM
finance.yahoo.com logoProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
finance.yahoo.com - April 18 at 8:08 AM
marketbeat.com logoHC Wainwright Weighs in on ProPhase Labs, Inc.'s Q1 2023 Earnings (NASDAQ:PRPH)
marketbeat.com - April 3 at 1:24 AM
finance.yahoo.com logoProPhase Labs' (NASDAQ:PRPH) investors will be pleased with their enviable 352% return over the last three years
finance.yahoo.com - March 31 at 10:29 AM
finance.yahoo.com logoProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2022 Earnings Call Transcript
finance.yahoo.com - March 30 at 8:48 AM
markets.businessinsider.com logoProPhase Labs is about to announce its earnings — here's what Wall Street expects
markets.businessinsider.com - March 29 at 3:29 PM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Prophase Labs (PRPH)
markets.businessinsider.com - March 29 at 3:29 PM
finance.yahoo.com logoProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
finance.yahoo.com - March 28 at 1:12 PM
finance.yahoo.com logoProPhase Labs, Inc. (PRPH) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 28 at 1:12 PM
Get ProPhase Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.



PRPH Media Mentions By Week

PRPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRPH
News Sentiment
▼
0.56

0.47
▲
Average
Medical
News Sentiment

PRPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRPH Articles
This Week
▼
2

1
▲
PRPH Articles
Average Week

Get ProPhase Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:PRPH) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -